StocksFundsScreenerSectorsWatchlists
WBA

WBA - Walgreens Boots Alliance Inc Stock Price, Fair Value and News

17.87USD-0.21 (-1.16%)Market Closed

Market Summary

WBA
USD17.87-0.21
Market Closed
-1.16%

WBA Alerts

  • 1 major insider buys recently.
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

WBA Stock Price

View Fullscreen

WBA RSI Chart

WBA Valuation

Market Cap

15.4B

Price/Earnings (Trailing)

-2.55

Price/Sales (Trailing)

0.11

EV/EBITDA

-1.98

Price/Free Cashflow

-8.73

WBA Price/Sales (Trailing)

WBA Profitability

EBT Margin

-9.84%

Return on Equity

-39.74%

Return on Assets

-7.17%

Free Cashflow Yield

-11.46%

WBA Fundamentals

WBA Revenue

Revenue (TTM)

144.6B

Rev. Growth (Yr)

6.28%

Rev. Growth (Qtr)

0.94%

WBA Earnings

Earnings (TTM)

-6.0B

Earnings Growth (Yr)

-940.4%

Earnings Growth (Qtr)

-8.7K%

Breaking Down WBA Revenue

Last 7 days

-6.6%

Last 30 days

-15.1%

Last 90 days

-23.2%

Trailing 12 Months

-50.1%

How does WBA drawdown profile look like?

WBA Financial Health

Current Ratio

0.66

Debt/Equity

0.5

Debt/Cashflow

0.01

WBA Investor Care

Dividend Yield

7.75%

Dividend/Share (TTM)

1.68

Shares Dilution (1Y)

0.01%

Diluted EPS (TTM)

-7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024144.6B000
2023133.3B136.1B139.1B142.4B
2022135.9B134.5B132.7B132.2B
2021125.0B128.6B132.5B135.0B
2020129.8B125.6B122.0B123.5B
2019136.1B136.4B136.9B133.0B
2018124.0B128.2B131.5B134.6B
2017116.1B116.7B118.2B120.5B
2016116.5B117.2B117.4B116.8B
201584.6B94.0B103.4B112.9B
201474.3B75.3B76.4B77.6B
20130072.2B73.3B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Walgreens Boots Alliance Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 02, 2024
mahajan manmohan
bought
116,280
19.38
6,000
evp and global cfo
Mar 01, 2024
brown tracey d
acquired
-
-
11,219
evp, pres., walgreens retail
Mar 01, 2024
mahajan manmohan
acquired
-
-
101,874
evp and global cfo
Mar 01, 2024
fabbri beth amber l.
acquired
-
-
14,052
chief corp. affairs officer
Mar 01, 2024
heckman todd
acquired
-
-
12,541
svp, global controller and cao
Jan 29, 2024
jarrett valerie b
bought
99,992
22.44
4,456
-
Jan 16, 2024
schlichting nancy m
sold
-350,567
23.05
-15,209
-
Jan 05, 2024
wentworth timothy c
bought
242,220
24.222
10,000
chief executive officer
Nov 10, 2023
gates richard p.
sold
-20,450
20.45
-1,000
svp, chief pharmacy officer
Nov 01, 2023
gray danielle
acquired
-
-
134,021
evp and global clo

1–10 of 50

Which funds bought or sold WBA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
Opal Wealth Advisors, LLC
new
-
2,517
2,517
-%
Apr 11, 2024
City State Bank
unchanged
-
-3,000
14,000
0.01%
Apr 11, 2024
Bangor Savings Bank
reduced
-37.09
-10,183
11,149
-%
Apr 11, 2024
Shilanski & Associates, Inc.
added
5.26
-36,818
256,396
0.09%
Apr 11, 2024
OPTIMUM INVESTMENT ADVISORS
reduced
-4.36
-12,322
47,557
0.02%
Apr 11, 2024
Hummer Financial Advisory Services Inc
reduced
-0.91
-50,613
235,553
0.19%
Apr 11, 2024
SANDERS MORRIS HARRIS LLC
added
373
1,832,440
2,437,910
0.45%
Apr 11, 2024
RFG Advisory, LLC
reduced
-16.9
-116,093
258,796
0.01%
Apr 11, 2024
Ballentine Partners, LLC
sold off
-100
-200,864
-
-%
Apr 11, 2024
MEYER HANDELMAN CO
sold off
-100
-1,582,920
-
-%

1–10 of 50

Are Funds Buying or Selling WBA?

Are funds buying WBA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own WBA
No. of Funds

Unveiling Walgreens Boots Alliance Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.62%
83,138,208
SC 13G/A
Jan 29, 2024
state street corp
6.28%
54,285,227
SC 13G/A
Jan 26, 2024
blackrock inc.
7.6%
65,892,675
SC 13G/A
Oct 10, 2023
vanguard group inc
10.04%
86,673,303
SC 13G/A
Feb 09, 2023
vanguard group inc
7.13%
61,519,967
SC 13G/A
Feb 07, 2023
state street corp
6.68%
57,573,619
SC 13G/A
Jan 31, 2023
blackrock inc.
7.0%
60,606,871
SC 13G/A
Feb 14, 2022
state street corp
5.45%
47,095,044
SC 13G/A
Feb 07, 2022
blackrock inc.
6.4%
55,032,519
SC 13G/A
Feb 11, 2021
state street corp
5.43%
46,922,371
SC 13G

Recent SEC filings of Walgreens Boots Alliance Inc

View All Filings
Date Filed Form Type Document
Apr 02, 2024
4
Insider Trading
Mar 28, 2024
10-Q
Quarterly Report
Mar 28, 2024
3
Insider Trading
Mar 28, 2024
8-K
Current Report
Mar 28, 2024
8-K
Current Report
Mar 15, 2024
3
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading

Peers (Alternatives to Walgreens Boots Alliance Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
355.4B
85.2B
-8.42% -11.18%
10.11
4.17
6.46% 95.94%
318.5B
60.1B
2.93% 8.79%
872.48
5.3
1.40% -97.49%
146.0B
46.5B
-8.36% -37.64%
-105.17
3.14
42.59% -114.62%
143.2B
28.2B
-3.17% 6.28%
21.32
5.08
7.09% 2.52%
84.8B
27.1B
-10.35% -18.24%
14.97
3.13
-0.60% 23.36%
14.9B
15.8B
-2.56% 43.63%
-25.86
0.94
6.17% 76.47%
MID-CAP
4.1B
4.7B
-2.22% -17.04%
-323.64
0.88
4.58% 90.97%
4.1B
1.7B
-15.21% -18.31%
11.46
2.45
49.61% 324.78%
3.2B
8.8B
-5.60% 16.18%
-5.41
0.37
7.79% -163.11%
1.9B
644.4M
-8.96% -5.30%
13.86
2.96
29.14% 50.51%
SMALL-CAP
1.4B
743.2M
9.58% -25.31%
-4.02
1.91
24.65% 80.36%
22.9M
70.0M
-16.39% -47.35%
-2.23
0.38
-19.54% -109.18%
19.0M
-
-4.27% 58.66%
-1.03
0.22
2882.68% -138.52%
1.1M
19.6M
-49.30% -95.63%
-0.07
0.05
80.00% 43.08%
819.8K
117.6M
-89.85% -87.50%
0
0.01
-0.79% -283.60%

Walgreens Boots Alliance Inc News

Latest updates
Defense World21 hours ago
The Motley Fool10 Apr 202411:45 am
Walgreens Boots Alliance Investor Relations28 Mar 202407:00 am

Walgreens Boots Alliance Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue0.9%37,05236,70735,42235,41534,86233,38232,44932,59733,75633,90134,26234,03032,77931,43830,37130,36431,33629,91233,95434,59134,528
Gross Profit4.0%7,0416,7716,4756,5887,0556,9536,4106,5727,7087,5747,5037,1536,7816,6306,3245,9597,0176,7777,2287,4537,754
  S&GA Expenses15.6%7,9216,8516,9907,1236,93413,1587,3207,0196,5656,3916,6506,1166,0295,7925,5777,8845,9096,2624,7236,2356,320
EBITDA Margin-553.5%-0.08*0.02*-0.02*-0.02*-0.02*-0.02*0.05*0.06*0.07*0.07*0.04*0.03*0.01*0.01*0.02*------
Interest Expenses39.4%13899.0015617314111010610810086.0088.00545137136147148156166121187181
Income Taxes-956.8%-782-74.00-151-33070.00-1,447-235-24217227558624642.00-207206-43.0014932.0015.00156226
Earnings Before Taxes-3563.1%-13,114-358-374-382607-5,270-758-18.009473,814907749946-607460-1,8621,0088825401,1981,356
EBT Margin-2661.0%-0.10*0.00*-0.04*-0.04*-0.04*-0.04*0.03*0.04*0.05*0.05*0.02*0.01*-0.01*-0.01*0.00*------
Net Income-8717.9%-5,908-67.00-180118703-3,721-4152898833,5806271,1971,026-308373-1,7089468456771,0251,156
Net Income Margin-1135.7%-0.04*0.00*-0.02*-0.02*-0.02*-0.02*0.03*0.04*0.05*0.05*0.02*0.02*0.00*-0.01*0.00*------
Free Cashflow-25.7%-989-787555-545248-117-4071,2586696458671,4451,1007641,674------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-13.9%84,20797,82396,62898,605100,47992,87590,12492,75992,68396,50781,28591,92090,92089,16787,17486,44490,00390,80767,59868,58670,434
  Current Assets-4.5%16,56117,34515,50316,54217,68919,52316,90218,87216,82420,31415,81426,60726,08421,08418,07318,32618,90919,60418,70019,02119,851
    Cash Equivalents-8.8%7157847398711,0884,3142,5584,5412,0274,2685591,8031,3111,3397469439881,0001,207768792
  Inventory-9.5%8,5579,4548,2578,1648,7579,3228,3538,5208,9479,4758,1598,3338,54111,1807,9179,5639,65210,5369,3339,87410,188
  Net PPE-----------------13,48213,62013,47813,71713,828
  Goodwill-43.9%15,81428,18428,18728,37192.0022,58222,28021,90121,9588,16612,42112,49312,46815,29912,01314,94816,78816,80013,54216,717-
Liabilities-1.7%68,84370,06668,14069,08670,88268,13759,71761,60261,00463,14157,14569,01468,98568,42666,038------
  Current Liabilities-4.6%24,91526,11624,53526,17028,22828,03622,58324,06722,69924,44722,05434,47531,24630,37927,07026,64928,66229,49425,76925,06025,303
  Short Term Borrowings16.0%1,9371,6709173,0614,2223,9381,0592,7872,1052,6471,3057,9635,1615,2453,2654,3795,9846,2255,7385,4835,356
  Long Term Debt-100.0%-7,5858,1458,8418,8207,78910,61510,67011,20311,1997,6757,73210,99810,97312,20312,11110,62510,62811,09812,12712,685
    LT Debt, Non Current-0.7%7,5357,5858,1458,8418,8207,78910,61510,67011,20311,1997,6757,73210,99810,97312,20312,11110,62510,62811,09812,12712,685
Shareholder's Equity-22.0%15,19219,48120,02021,06329,43924,58229,36630,38230,86730,57923,82222,59621,62520,56321,13621,32324,33424,31424,15224,77125,413
  Retained Earnings-18.8%26,44832,57333,05833,65433,95233,66437,80138,63238,75738,28635,12134,90834,11633,49534,21034,24436,35135,81035,81535,54734,928
  Additional Paid-In Capital0.1%10,62710,61710,66110,66710,62910,47710,95011,02910,97310,96610,98810,97110,91610,87610,76110,72610,68910,64810,63910,60510,571
Shares Outstanding0.0%863863863863863864864864864866865865-865879------
Minority Interest-78.9%1,7088,1078,3028,2968,2474,0064,091--4,316402495514506498586615653641638643
Float-----25,400-23,200-----23,200---33,500---54,500
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-126.7%-637-2811,039-20.0074649386.001,6291,0851,0991,2451,7541,3611,1952,0869141,4231,0612,3792,020735
  Share Based Compensation-5.9%48.0051.0037.0055.0071.0022212596.0013535.0035.0050.0034.0036.0036.0034.0039.0028.0032.0024.0036.00
Cashflow From Investing861.2%81785.00155334-5,4411,858198919-223-1,9585,41315.00-1,097-259-637-43.00-215-402-738-523-411
Cashflow From Financing-268.3%-313186-1,460-1,1932,365-599-2,252-16.00-3,1083,877-7,180-1,209-295-352-1,649-913-1,219-866-1,474-1,458-505
  Dividend Payments-0.5%413415415415414415408418420413405404403405487403447410399403419
  Buy Backs-100.0%-69.00---150--33.00154---1102154614404734346132,201

WBA Income Statement

2024-02-29
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
Income Statement [Abstract]    
Sales$ 37,052$ 34,862$ 73,760$ 68,244
Cost of sales30,01227,80759,94854,236
Gross profit7,0417,05513,81114,008
Selling, general and administrative expenses7,9216,93414,77220,091
Impairments12,369012,3690
Equity earnings in Cencora7975120129
Operating (loss) income(13,171)197(13,209)(5,954)
Other income (expense), net195552(25)1,544
(Loss) earnings before interest and income tax (benefit) provision(12,976)749(13,235)(4,410)
Interest expense, net138141237252
(Loss) earnings before income tax (benefit) provision(13,114)607(13,472)(4,662)
Income tax (benefit) provision(782)70(856)(1,377)
Post-tax earnings from other equity method investments1061613
Net (loss) earnings(12,322)544(12,600)(3,272)
Net loss attributable to non-controlling interests(6,415)(159)(6,625)(253)
Net (loss) earnings attributable to Walgreens Boots Alliance, Inc.$ (5,908)$ 703$ (5,975)$ (3,018)
Earnings Per Share, Basic [Abstract]    
Total (in dollars per share)$ (6.85)$ 0.81$ (6.93)$ (3.50)
Earnings Per Share, Diluted [Abstract]    
Total (in dollars per share)$ (6.85)$ 0.81$ (6.93)$ (3.50)
Weighted average common shares outstanding:    
Basic (in shares)862.5862.6862.8863.1
Diluted (in shares)862.5863.4862.8863.1

WBA Balance Sheet

2024-02-29
CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)
$ in Millions
Feb. 29, 2024
Aug. 31, 2023
Current assets:  
Cash and cash equivalents$ 668$ 739
Accounts receivable, net6,2005,381
Inventories8,5578,257
Other current assets1,1361,127
Total current assets16,56115,503
Non-current assets:  
Property, plant and equipment, net10,12111,587
Operating lease right-of-use assets21,34221,667
Goodwill15,81428,187
Intangible assets, net12,98413,635
Equity method investments (see Note 5)3,2563,497
Other non-current assets4,1282,550
Total non-current assets67,64681,125
Total assets84,20796,628
Current liabilities:  
Short-term debt1,937917
Trade accounts payable (see Note 16)12,77512,635
Operating lease obligations2,3392,347
Accrued expenses and other liabilities7,5228,426
Income taxes342209
Total current liabilities24,91524,535
Non-current liabilities:  
Long-term debt7,5358,145
Operating lease obligations21,81222,124
Deferred income taxes1,2381,318
Accrued litigation obligations6,1236,261
Other non-current liabilities7,2205,757
Total non-current liabilities43,92843,605
Commitments and contingencies (see Note 10)
Total liabilities68,84368,140
Redeemable non-controlling interests172167
Equity:  
Preferred stock $.01 par value; authorized 32 million shares, none issued00
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at February 29, 2024 and August 31, 20231212
Paid-in capital10,62710,661
Retained earnings26,44833,058
Accumulated other comprehensive loss(2,897)(2,993)
Treasury stock, at cost; 309,800,252 shares at February 29, 2024 and 308,839,832 shares at August 31, 2023(20,705)(20,717)
Total Walgreens Boots Alliance, Inc. shareholders’ equity13,48420,020
Non-controlling interests1,7088,302
Total equity15,19228,322
Total liabilities, redeemable non-controlling interests and equity$ 84,207$ 96,628
WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
 CEO
 WEBSITEwalgreensbootsalliance.com
 INDUSTRYPharmaceuticals
 EMPLOYEES65535

Walgreens Boots Alliance Inc Frequently Asked Questions


What is the ticker symbol for Walgreens Boots Alliance Inc? What does WBA stand for in stocks?

WBA is the stock ticker symbol of Walgreens Boots Alliance Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Walgreens Boots Alliance Inc (WBA)?

As of Fri Apr 12 2024, market cap of Walgreens Boots Alliance Inc is 15.42 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of WBA stock?

You can check WBA's fair value in chart for subscribers.

What is the fair value of WBA stock?

You can check WBA's fair value in chart for subscribers. The fair value of Walgreens Boots Alliance Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Walgreens Boots Alliance Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for WBA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Walgreens Boots Alliance Inc a good stock to buy?

The fair value guage provides a quick view whether WBA is over valued or under valued. Whether Walgreens Boots Alliance Inc is cheap or expensive depends on the assumptions which impact Walgreens Boots Alliance Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for WBA.

What is Walgreens Boots Alliance Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, WBA's PE ratio (Price to Earnings) is -2.55 and Price to Sales (PS) ratio is 0.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. WBA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Walgreens Boots Alliance Inc's stock?

In the past 10 years, Walgreens Boots Alliance Inc has provided -0.1 (multiply by 100 for percentage) rate of return.